Degrader-Antibody Conjugates – Talk Bio

Actionable Insights Powered by AI

Orum Therapeutics Appoints Chad May as Chief Scientific Officer

3 weeks ago talkbio0Tagged Chad, CSO, decitabine, Degrader-Antibody Conjugates, Month of May, Orum Therapeutics, Targeted Protein Degradation

Orum Therapeutics; Chad May; CSO; Degrader-Antibody Conjugates; DAC; Targeted Protein Degradation

Revolutionary Protein Degraders Integrated into Antibody-Drug Conjugates: Carolyn Bertozzi and Versant Launch New Biotech with $94 Million Funding

2 years ago talkbio0Tagged Antibody-Drug Conjugates, Bertozzi, Carolyn, DACs, Degrader-Antibody Conjugates, Firefly Bio, Protein degraders, Ventures, Versant

Carolyn Bertozzi, Versant Ventures, Firefly Bio, Protein degraders, Antibody-drug conjugates (ADCs), Degrader-Antibody Conjugates (DACs), $94 million funding